Pay in 4 interest-free payments of $6.35 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
It is classified as a research chemical, meaning: It cannot be legally marketed as a drug or supplement It is not recognized as "Generally Recognized as Safe" (GRAS) No New Drug Application (NDA) has been submitted It has not undergone the formal FDA approval process Research Chemical Status BPC-157 is available for purchase as a "research chemical" in most jurisdictions, with important caveats: Sold for "research purposes only" Not for human consumption (legally) No quality standards enforced by regulatory agencies Purity and identity depend entirely on supplier integrity International Regulations Regulatory status varies by country: United States : Research chemical, not approved for human use European Union : Not approved, status varies by member state Canada : Not approved for human use, research chemical Australia : Not approved, TGA Category 4 substance United Kingdom : Not approved for human use Sports and Competition BPC-157 is not specifically listed on the World Anti-Doping Agency (WADA) prohibited list, unlike TB-500
Two-year safety and clinical outcomes in chronic ischemic stroke patients after implantation of modified bone marrow-derived mesenchymal stem cells (SB623): a phase 1/2a study
Our diagnostic codes hub brings together the most widely used clinical coding frameworks helping clinicians, billers, and healthcare organizations access trusted information in one place
Contact us today and take the first step toward a healthier, more vibrant you!
Understanding chronic hepatitis deltas (CHD) ability to cause rapid and reproducible progression of liver disease will not only aid development of improved staging techniques and sorely needed therapeutics for CHD but will also allow for a deeper understanding of chronic liver disease (CLD) progression in general
US$ 26.63
US$ 22.76
US$ 22.04
US$ 27.62
US$ 22.74
